跳至主要内容
临床试验/CTRI/2024/03/064942
CTRI/2024/03/064942尚未招募2 期

A Randomized, Parallel Group, Open Label, Active Controlled Clinical Study to Evaluate the Safety and Efficacy of a Unani Formulation in the Management of Mutal ?zima Mabya ?-i-Muta‘ddad al-Kis ?t (Polycystic Ovarian Syndrome) - NI

ATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS HYDERABAD0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Participants of PCOS as diagnosed by Rotterdam Criteria
  • Clinical Hyperandrogenism
  • Biochemical Hyperandrogenism (Raised Testosterone)
  • Evidence of Oligo-anovulation
  • Oligo-amenorrhea
  • Polycystic Ovarian Morphology (PCOM) on USG

排除标准

  • Patients having congenital uterine abnormalities
  • Patients with history of Hormone Replacement Therapy, or using any other long-term medication
  • Patients with known active systemic diseases
  • Known Cases of Hypothyroidism, severe Hyperprolactinemia Diabetes Mellitus and other immunocompromised disorders
  • Pregnant or Lactating women
  • Participants not willing to give consent and to attend treatment schedule regularly

研究者

发起方
ATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS HYDERABAD

相似试验